15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Adagene Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $7.00 to $10.00, a moderate spread. The average target of $8.25 sits 134% above the current $3.52. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near -100% this year and 0% next, consensus EPS building from about $-0.19 next quarter toward $-0.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Adagene Inc.
As of Jul, 4 of 4 firms rate ADAG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ADAG EPS & revenue forecast
EPS · NEXT QUARTER
$-0.19
Range $-0.19 – $-0.19 · 1 analysts
Next period, 1 analysts expect Adagene Inc to earn $-0.19 a share (range $-0.19 – $-0.19), versus — a year earlier. Full-year consensus is $-0.51, growing to $-0.52 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $3.6M, rising to $4.5M next year.
Top analysts covering Adagene Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ADAG.
#1
Arthur He
HC Wainwright & Co. · Rank #150
Buy
$7.00+98.9% to target
Overall win rate
48%
+ Follow
#2
Daina Graybosch
Leerink Partners
Buy
$7.00+98.9% to target
Coverage
—
+ Follow
#3
PJ
Paul Jeng
Guggenheim
Buy
$10.00+184.1% to target
Coverage
—
+ Follow
#4
MS
Maxwell Skor
Morgan Stanley
Hold
No targeton ADAG
Coverage
—
+ Follow
#5
CL
Christopher Liu
LUCID CAPITAL MARKETS
Buy
$9.00+155.7% to target
Coverage
—
+ Follow
ADAG stock forecast FAQ
What is ADAG's average 12-month price target?+
The 4 analysts with a live target average $8.25 for Adagene Inc over the next 12 months, ranging from a $10.00 high to a $7.00 low.
Is ADAG stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ADAG?+
The Street-high target is $10.00 (Guggenheim), and the Street-low is $7.00 (HC Wainwright & Co.). The average of all 4 active targets is $8.25.
How many Wall Street analysts cover ADAG?+
4 analysts have an active rating on Adagene Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering ADAG?+
Among analysts who currently cover ADAG, Arthur He of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #150). Their current call is Buy with a $7.00 target.
What is Adagene Inc's projected EPS for next quarter?+
The consensus estimate is $-0.19 per share (range $-0.19 – $-0.19) across 1 analysts. Full-year EPS is projected at $-0.51, rising to $-0.52 the following year.
How much revenue is Adagene Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $3.6M, growing to $4.5M next year.
Have analysts been upgrading or downgrading ADAG lately?+
As of Jul, 4 of 4 firms rate ADAG a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ADAG calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
